4SC AG INH. O.N./ DE000A3E5C40 /
| 2024-08-02 7:24:31 PM | Chg. -0.070 | Volume | Bid7:24:31 PM | Ask7:24:31 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 4.440EUR | -1.55% | - Turnover: - |
4.440Bid Size: - | 4.680Ask Size: - | 46.02 mill.EUR | 0.00% | - |
GlobeNewswire
2023-12-05
Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronch...
GlobeNewswire
2019-04-01
Dynavax’s SD-101 and 4SC’s Domatinostat Demonstrate Synergy and Induce a Systemic Anti-tumor Respons...
GlobeNewswire
2018-06-11
Global Pharma and Biotech Discovery Stage Partnering Terms and Agreements Directory 2012-2018
